These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33902424)

  • 61. Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
    Hamilton EP; Kaklamani V; Falkson C; Vidal GA; Ward PJ; Patre M; Chui SY; Rotmensch J; Gupta K; Molinero L; Li Y; Emens LA
    Clin Breast Cancer; 2021 Dec; 21(6):539-551. PubMed ID: 34154926
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
    Ozaki Y; Aoyama Y; Masuda J; Inagaki L; Kawai S; Shibayama T; Maeda T; Kurata M; Yoshida K; Saeki S; Hosonaga M; Fukada I; Hara F; Kobayashi T; Kobayashi K; Miyake S; Takano T; Ueno T; Ohno S
    BMC Cancer; 2022 Jan; 22(1):36. PubMed ID: 34983437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer.
    Kolarova I; Vanasek J; Odrazka K; Melichar B; Ryska A; Petera J; Vosmik M; Dolezel M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):285-292. PubMed ID: 31831888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
    Singer CF; Pfeiler G; Hubalek M; Bartsch R; Stöger H; Pichler A; Petru E; Bjelic-Radisic V; Greil R; Rudas M; Maria Tea MK; Wette V; Petzer AL; Sevelda P; Egle D; Dubsky PC; Filipits M; Fitzal F; Exner R; Jakesz R; Balic M; Tinchon C; Bago-Horvath Z; Frantal S; Gnant M;
    Eur J Cancer; 2020 Jun; 132():43-52. PubMed ID: 32325419
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress.
    Javid H; Attarian F; Saadatmand T; Rezagholinejad N; Mehri A; Amiri H; Karimi-Shahri M
    J Cell Biochem; 2023 Apr; 124(4):477-494. PubMed ID: 36966454
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.
    Singh S; Numan A; Maddiboyina B; Arora S; Riadi Y; Md S; Alhakamy NA; Kesharwani P
    Drug Discov Today; 2021 Jul; 26(7):1721-1727. PubMed ID: 33745879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer.
    Noguchi E; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):321-332. PubMed ID: 33324990
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Meng X; Liu Y; Zhang J; Teng F; Xing L; Yu J
    Cancer Lett; 2017 Oct; 405():29-37. PubMed ID: 28688973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New and Emerging Targeted Therapies for Advanced Breast Cancer.
    Lau KH; Tan AM; Shi Y
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216405
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunotherapy: New insights in breast cancer treatment.
    Alshehri B
    Hum Antibodies; 2021; 29(3):193-202. PubMed ID: 33998534
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate.
    Kotecki N; Gombos A; Awada A
    Expert Rev Anticancer Ther; 2019 Jun; 19(6):447-454. PubMed ID: 31082272
    [No Abstract]   [Full Text] [Related]  

  • 73. Breast cancer epigenetics: current and evolving treatment.
    Purja S; Nguyen DT; Kim E
    Breast Cancer; 2024 Sep; 31(5):869-885. PubMed ID: 38861041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer.
    Püsküllüoğlu M; Michalak I
    Front Pharmacol; 2024; 15():1349242. PubMed ID: 38500769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting breast cancer stem cells directly to treat refractory breast cancer.
    Pan L; Han J; Lin M
    Front Oncol; 2023; 13():981247. PubMed ID: 37251931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neutrophils as potential therapeutic targets for breast cancer.
    Gong YT; Zhang LJ; Liu YC; Tang M; Lin JY; Chen XY; Chen YX; Yan Y; Zhang WD; Jin JM; Luan X
    Pharmacol Res; 2023 Dec; 198():106996. PubMed ID: 37972723
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metastatic Breast Cancer: Review of Emerging Nanotherapeutics.
    Dissanayake R; Towner R; Ahmed M
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adoption and use of immunotherapy in breast cancer management in Africa: barriers and prospect - a narrative review.
    Mutiu Alani J; Olaoye DQ; Adesina Abass AS
    Ann Med Surg (Lond); 2023 Dec; 85(12):6041-6047. PubMed ID: 38098562
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunotherapy in Breast Cancer: the New Frontier.
    Hu ZI; McArthur HL
    Curr Breast Cancer Rep; 2018; 10(2):35-40. PubMed ID: 29881518
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer.
    Hu Y; Li Y; Yao Z; Huang F; Cai H; Liu H; Zhang X; Zhang J
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.